Cisplatin and Infectious pleural effusion - a phase IV clinical study of FDA data

Summary:

Infectious pleural effusion is reported as a side effect among people who take Cisplatin (cisplatin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Docetaxel, and have Oesophageal carcinoma.

The phase IV clinical study analyzes which people have Infectious pleural effusion when taking Cisplatin. It is created by eHealthMe based on reports of 92,672 people who have side effects when taking Cisplatin from the FDA, and is updated regularly.

What is Cisplatin?

Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.

What is Infectious pleural effusion?

Infectious pleural effusion (infectious fluid in the lung) is found to be associated with 157 drugs and 347 conditions by eHealthMe. Check the latest studies of Infectious pleural effusion.

On Jul, 06, 2026

92,672 people reported to have side effects when taking Cisplatin.
Among them, 26 people (0.03%) have Infectious pleural effusion.

Could Cisplatin cause Infectious pleural effusion?

Among these 26 people:

How long have people been on Cisplatin when they have Infectious pleural effusion? *

What is the gender of people who have Infectious pleural effusion when taking Cisplatin? *

female: 8.7 %
male: 91.3 %

What is the age of people who have Infectious pleural effusion when taking Cisplatin? *

What are other drugs people take besides Cisplatin? *

What are other side effects people have besides Infectious pleural effusion? *

Fever: 5 people, 19.23%
Renal Impairment (severely reduced kidney function): 5 people, 19.23%
Oesophageal Perforation (hole in oesophagus): 5 people, 19.23%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 15.38%
Mediastinitis (inflammation of the tissues in the mid-chest): 4 people, 15.38%
Haemorrhagic Tumor Necrosis: 3 people, 11.54%
Myelosuppression (a decrease in the production of blood cells): 3 people, 11.54%
Metastases To Liver (cancer spreads to liver): 3 people, 11.54%
Pneumonia: 3 people, 11.54%
Thyroid Diseases: 3 people, 11.54%

What are the existing conditions these people have? *

Oesophageal Squamous Cell Carcinoma (cancer that begins in flat cells lining the oesophagus): 5 people, 19.23%
Oesophageal Carcinoma (cancer tumour of oesophagus): 5 people, 19.23%
Oesophageal Squamous Cell Carcinoma Stage Iv (the cancer has spread to distant lymph nodes or other sites): 3 people, 11.54%
Metastases To Lung (cancer spreads to lung): 3 people, 11.54%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 2 people, 7.69%
Oesophageal Cancer Metastatic (cancer of oesophagues spreads to other part): 2 people, 7.69%
Hypopharyngeal Cancer: 2 people, 7.69%
Gastric Cancer Stage I (the tumour has invaded only the sub mucosa. cancer cells may be found in up to 6 lymph nodes): 2 people, 7.69%
Nausea And Vomiting: 1 person, 3.85%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Cisplatin and have Infectious pleural effusion?

- Check whether Infectious pleural effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cisplatin:

Cisplatin (92,837 reports)

Browse all side effects of Cisplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infectious pleural effusion:

Infectious pleural effusion (157 drugs)

Browse all the conditions that are associated with Infectious pleural effusion:

Infectious pleural effusion (347 conditions)

Related publications that referenced our studies

Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cisplatin (the active ingredients of Cisplatin) and Cisplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.